Development and calibration of suitably accurate functional assays for BRCA1 RING domain and BRCT domain missense substitutions could dramatically accelerate clinical classification of rare missense substitutions observed in that gene. Leveraging data from 68,000 full sequence tests of BRCA1 and BRCA2, plus data from the limited number of already classified BRCA1 RING domain missense substitutions, we used logistic regression and related techniques to evaluate three BRCA1 RING domain assays. These were recently described high throughput yeast 2-hybrid and E3 ubiquitin ligase assays, plus a newly developed mammalian 2-hybrid assay. While there were concerns about the accuracy of the yeast 2-hybrid assay and the indirect nature of the ubiquitin ligase assay, the mammalian 2-hybrid assay had excellent correlation with existing missense substitution classifications. After calibration, this assay contributed to classification of one newly reported BRCA1 missense substitution. In principal, the mammalian 2-hybrid assay could be converted to a high-throughput format that would likely retain suitable accuracy.
INTRODUCTION!
BRCA1! and! its! heterodimerization! partner! BARD1! share! two! highly! conserved! domains:! an! N7 terminal!RING!domain!and!a!pair!of!C7terminal!BRCT!repeats.!!Even!though!the!RING!and!BRCT! domains!comprise!only!about!17%!of!the!length!of!BRCA1,!all!of!the!missense!substitutions!in! this! protein! that! are! known! to! be! pathogenic! occur! in! one! of! these! two! domains! (http://hci7 exlovd.hci.utah.edu/home.php?select_db=BRCA1),! unless! the! underlying! nucleotide! change! is! spliceogenic.! ! While! severely! dysfunctional! missense! substitutions! in! either! of! these! domains! are!associated!with!increased!cancer!risk! (reviewed!in!Clark!et!al.,!2012) ,!it!is!still!unclear!how! non7spliceogenic!RING!missense!substitutions!elicit!their!pathogenicity!! In! contrast! with! protein! truncating! variants,! it! is! often! difficult! to! know! what! effect,! if! any,! missense! substitutions! will! have! on! protein! function.! ! Over! the! last! 12! years,! we! and! others! have!developed!a!Bayesian!"integrated!evaluation"!or!"multifactorial!model"!for!evaluation!of! Variants!of!Unclear!Significance!(VUS)!in!BRCA1!and!BRCA2! (Easton!et!al.,!2007; .!!This!integrated!evaluation!combines!a!sequence!analysis7based!prior!probability! of! pathogenicity! (Prior_P)! ! Vallée! et! al.,! 2016) ! with! observational! data! from! the! patient! and/! or! tumor,! expressed! as! odds! in! favor! of! pathogenicity! (Odds_Path)! to! arrive! at! a! posterior! probability! of! pathogenicity! (Post_P)! (Lindor! et! al.,! 2012; .!!The!resulting!posterior!probability!is!then!converted!to!one!of!five!qualitative!classes,! based! on! cutpoints! considered! to! be! clinically! relevant! (Plon! et! al.,! 2008) .! ! Using! this! quantitative! approach,! 155! missense! substitutions! have! now! been! classified! in! BRCA1! (http://hci7exlovd.hci.utah.edu/home.php?select_db=BRCA1).!!Of!these,!ten!are!located!in!the! RING!domain,!with!eight!falling!into!one!of!the!two!pathogenic!classes!(IARC!Class!4!or!5)!and! two!falling!into!one!of!the!two!neutral!classes!(IARC!Class!1!or!2).!! Two! well! recognized! activities! of! BRCA1! reside! in! its! first! 300! amino! acids.!!The! interval! from! roughly!Ala4!to!Ala102!encodes!a!C3HC4!RING!finger!and!a!set!of!helical!bundles!that!together! enable!heterodimerization!with!the!homologous!domain!of!BARD1! (Brzovic!et!al.,!2001 ;!L. !Wu! et!al.,!1996) .!!In!addition,!the!interval!from!roughly!Ala4!to!Asp300!encodes!E3!ubiquitin!ligase! activity! .!!The!BRCA1:BARD1!interaction!influences!the!abundance!and! stability!of!BRCA1!(W. !Wu!et!al.,!2010) ,!is!necessary!for!early!recruitment!of!BRCA1!to!sites!of! DNA! double! strand! breaks! (Li! &! Yu,! 2013),! and! fully! activates! the! BRCA1! E3! ubiquitin! ligase! activity! (Baer!&!Ludwig,!2002; !Brzovic!et!al.,!2003; !Hashizume!et!al.,!2001) .!!To!our!knowledge,! there!are!no!well7documented!BRCA1!seperation!of!function!mutations!that!severely!damage! the! BARD1! interaction! without! also! dramatically! reducing! E3! ubiquitin! ligase! activity.!!On! the! other! hand,! the! BRCA1! missense! substitution! p.Ile26Ala,! which! does! not! dramatically! reduce! BARD1! interaction,! specifically! disrupts! the! interaction! between! BRCA1! and! its! cognate! E2! ligases,!selectively!inhibiting!E3!ligase!activity!by!blocking!the!transfer!of!ubiquitin!to!substrates! bound!to!BRCA1! (Brzovic!et!al.,!2003; !W.!Wu!et!al.,!2008) .!!Interestingly,!mice!homozygous!for! this!RING!domain!separation!of!function!missense!substitution!are!no!more!tumor!prone!than! their! wild! type! littermates! (Shakya! et! al.,! 2011) .! ! In! contrast,! RING! variants! that! disrupt! heterodimer!formation!result!in!DNA!repair!defects!and!loss!of!tumor!suppression! (Ransburgh! et! al.,! 2010) .! Nonetheless,! Starita! et! al! reported! that! BRCA1:BARD1! heterodimer! formation! alone!is!a!poor!predictor!of!the!pathogenicity!of!RING!missense!substitutions,!implying!that!the! E3!ligase!activity!does!make!an!important!contribution! (Starita!et!al.,!2015) .!!! Previously,! we! used! data! from! 68,000! full! sequence! tests! of! BRCA1! and! BRCA2! performed! at! Myriad!Genetics!to!develop!and!calibrate!computational!algorithms!for!evaluation!of!missense! substitution!severity!and!splice!variant!severity!in!these!two!genes! !Vallée! et!al.,!2016) .!!Here,!linking!the!Myriad!BRCA1!test!data!to!the!nearly!comprehensive!Yeast!27 hybrid! BRCA1:BARD1! interaction! assay! data! and! phage! display! BRCA1! E3! ligase! activity! data! published!recently!by!Starita!et!al!(2015),!we!test!two!17sided!hypotheses:!(1)!as!measured!by! the! Starita! et! al! yeast! 27hybrid! assay,! that! loss! of! BRCA1:BARD1! interaction! is! predictive! of! pathogenicity,!and!(2)!as!measured!by!the!Starita!et!al!phage7display!E3!ligase!assay,!that!loss!of! BRCA1! auto7ubiquitination! is! predictive! of! pathogenicity.! ! Guided! by! the! results! from! these! hypothesis!tests,!we!develop!and!calibrate!an!accurate!functional!assay,!results!from!which!can! be!included!within!the!Bayesian!integrated!evaluation!framework!to!assess!the!pathogenicity!of! BRCA1!RING!missense!substitutions.!!We!then!report!progress!towards!conversion!of!that!assay! to! a! high7throughput! format! that! could! evaluate! all! possible! BRCA1! amino! domain! substitutions.!
METHODS!

Dataset!
The!dataset!comprised!results!of!full!sequence!tests!carried!out!at!Myriad!Genetic!Laboratories,! as! used! previously! in ! Easton! et! al.! (2007 ! for! modelling! of! risk! associated!with!BRCA1/2!sequence!variation.!!The!analyses!described!here!are!based!on!results! of! full! sequence! tests! of! both! genes! from! 68,000! BRACAnalysis! subjects! of! whom! 4,867! were! reported!to!carry!a!pathogenic!BRCA1!variant!and!3,561!were!reported!to!carry!a!pathogenic! BRCA2! variant.! ! For! a! test! to! have! been! performed,! a! test! request! form! must! have! been! completed! by! the! ordering! health! care! provider,! and! the! form! must! have! been! signed! by! an! appropriate!individual!indicating!that!"informed!consent!has!been!signed!and!is!on!file".!!The! mutation!screening!data!are!arranged!by!sequence!variant!rather!than!by!subject.!!The!dataset! includes! nucleotide! and! amino! acid! nomenclature! specifications! for! all! of! the! exonic! single! nucleotide! substitutions! -! silent,! missense,! or! nonsense! -! observed! from! the! 68,000! patient! mutations! screening! set;! these! are! all! of! the! observational! data! required! to! calculate! the! Enrichment!Ratio!for!Single!Nucleotide!Substitutions!(ERS)! .! Analyses! of! the! personal! and! family! history! of! tested! probands! to! calculate! family! history! likelihood!ratios!(FamHx7LRs)!derive!from!a!virtually!identical!series!of!subjects!used!previously! (Easton! et! al.,! 2007) .! ! However,! this! dataset! also! includes! frameshifts,! in7frame! indels,! and! sequence!variants!falling!in!the!intronic!portions!of!the!splice!junction!consensus!regions!from!7 20!to!+6!of!the!protein!coding!exons.!!We!refer!to!these!two!overlapping!data!sets!as!the!B1&2! 68K!set.! ! (2008) .! Then! all! of! the! summary! personal/family! histories! of! the! subjects! who! carried! the! variants! within! a! particular! stratum! were!used!to!estimate!α,!the!proportion!of!variants!within!that!stratum!that!were!pathogenic,! using! the! heterogeneity! likelihood! ratio! defined! in! (Easton! et! al.,! 2007) .! ! Approximate! 95%! confidence! intervals! for! the! heterogeneity! proportion! were! obtained! by! finding! the! values! α L ! and! α U ! for! which! the! overall! likelihood! differed! from! that! at! α! by! an! amount! equivalent! to! a! likelihood!ratio!test!significant!at!the!0.05!level! (Easton!et!al.,!2007) .!! 1FbyF1!mammalian!2Fhybrid!assay! Cell*line*development! The!firefly!luciferase!reporter!pGL4.31!(Promega),!was!re7engineered!for!puromycin!resistance,! and!then!stably!incorporated!into!HEK293!cells!(ATCC!CRL71573)!using!the!PiggyBac!transposon! system!(System!Biosciences).!!Chromatin!insulators!and!PiggyBac!terminal!repeats!were!added! to! each! end! of! the! reporter! to! block! transgene! silencing! and! facilitate! transposition,! respectively.!!These!sequences!were!PCR!amplified!from!PB531A72!(System!Biosciences).!! 500,000!HEK293!cells/well!were!plated!in!a!67well!plate!18724!hours!before!transfection.!!500! ng! of! PiggyBac! pGL4.31! Puro! and! 200! ng! of! PiggyBac! transposase! (PB200A71,! System! Biosciences)! were! co7transfected! with! 8! µl! of! FugeneHD! (Promega).! ! The! cells! were! then! subjected!to!one!week!of!selection!(2!μg/ml!puromycin),!at!which!point!individual!clones!were! transferred!to!967well!plates!via!FACS.!!Luciferase!activity!was!characterized!by!the!two7hybrid! system! described! below,! using! known! neutral! BRCA1! RING! missense! substitutions! and! WT! BARD1.! ! The! clone! with! the! highest! relative! luminescence! signal! (~1x10 6 ! RLU)! was! used! to! Table! 4 † This is a non-conservative substitution falling at a key domain invariant position in the reference BRCA1 protein multiple sequence alignment. The Align-GVGD Class is C65, resulting in the missense substitution severity Prior_P of 0.81. * p.P34S had 5.5% of wild-type activity in the calibrated mammalian 2-hybrid assay. • UAS:GAL4-GFP (2 nd genomic site)
• UAS:GAL4-RFP (3 rd genomic site)
Calibrate "Odds of Pathogenicity" as a function of % wt activity Figure 4 Assay incorporated in Bayesian Quantitative Integrated Evaluation
